Twenty-five novel imidazole N-H substituted Daclatasvir (BMS-790052, DCV) analogues (8a-8y) were designed and synthesized as potential prodrugs. Structure modifications were performed in order to improve potency and pharmacokinetic (PK) properties. All target compounds were evaluated in a hepatitis C virus (HCV) genotype 1b replicon, and the 2-oxoethyl acetate substituted compound 8t showed similar anti-HCV activity (EC50 = 0.08 nM) to that of the lead compound Daclatasvir. Moreover, the utility of prodrug 8t was demonstrated through similar exposure of the parent compound when the prodrugs were dosed in vivo. PK studies showed that prodrug 8t was an ideal candidate for a slower and sustained release form of Daclatasvir.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2015.06.006DOI Listing

Publication Analysis

Top Keywords

imidazole n-h
8
n-h substituted
8
hepatitis virus
8
design synthesis
4
synthesis imidazole
4
substituted amide
4
amide prodrugs
4
prodrugs inhibitors
4
inhibitors hepatitis
4
virus replication
4

Similar Publications

A mitochondria-targeted iridium(III) complex-based sensor for endogenous GSH detection in living cells.

Analyst

January 2025

Jiangxi Provincial Key Laboratory of Organic Functional Molecules; Institute of Organic Chemistry, Jiangxi Science and Technology Normal University, Nanchang 330013, PR China.

Glutathione (GSH) plays an important role in maintaining redox homeostasis in biological systems. Development of reliable glutathione sensors is of great significance to better understand the role of biomolecules in living cells and organisms. Based on the advantages of the photophysical properties of iridium complexes, we proposed a "turn-on" phosphorescent sensor.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on synthesizing and analyzing the structure of a compound featuring imidazolium ions as countercations, based on previously known crystal structures.
  • Various techniques, including thermal stability assessments and spectral analysis, reveal differences in how the pentadentate chelator µ-EDTA interacts with copper centers in two different compounds.
  • The findings highlight the impact of imidazolium ions on the magnetic properties and stability of the structures, supported by DFT calculations showing significant hydrogen bonding and stacking interactions within the trinuclear anion.
View Article and Find Full Text PDF

Background: Variable benefits have been reported from the adjunctive use of simvastatin and the 5HT3 receptor antagonist, ondansetron, in patients with schizophrenia. We investigated their independent efficacy and possible synergy to improve negative symptoms of schizophrenia within a single trial.

Methods: A 6-month, randomised, double-blind, placebo-controlled trial with a 4-arm, 2 × 2 factorial design, in three centres in Pakistan.

View Article and Find Full Text PDF

Melanoma is a skin cancer that arises from melanocytes and can spread quickly to the other organs of the body, if not treated early. Generally, melanoma shows an inherent resistance to conventional therapies. In this regard, new potential drugs are being developed as possible treatments for melanoma.

View Article and Find Full Text PDF

Supramolecular architectures in multicomponent crystals of imidazole-based drugs and trithiocyanuric acid.

Acta Crystallogr B Struct Sci Cryst Eng Mater

August 2024

University of Lodz, Faculty of Chemistry, Pomorska 163/165, 90-236 Łódź, Poland.

The structures of three multicomponent crystals formed with imidazole-based drugs, namely metronidazole, ketoconazole and miconazole, in conjunction with trithiocyanuric acid are characterized. Each of the obtained adducts represents a different category of crystalline molecular forms: a cocrystal, a salt and a cocrystal of salt. The structural analysis revealed that in all cases, the N-H.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!